Catalyst Funds Management Pty LTD Care Dx, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 5,000 shares of CDNA stock, worth $114,350. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$114,350% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding CDNA
# of Institutions
219Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$104 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$71.9 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$68.3 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$46.6 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.22B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...